Skip to main content
. 2019 Mar 27;2(3):e00064. doi: 10.1002/edm2.64

Figure 2.

Figure 2

A, All‐cause mortality rate higher in patients with lower baseline total testosterone compared to normal baseline total testosterone. B, All‐cause mortality rate higher in patients with lower baseline dihydrotestosterone compared to normal baseline dihydrotestosterone. C, All‐cause mortality rate higher in patients with lower baseline free testosterone compared to normal baseline free testosterone